At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 124 enrolled
Drug / intervention
Tranexamic acid +1 moredrug
Likely dose
Tranexamic acid 25mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Study on the Topical Application of Tranexamic Acid to Wound Bed for Hemostasis in the Setting Granulating Wounds Following Mohs Micrographic Surgery
In Brief
A Early Phase 1 clinical trial evaluating Tranexamic acid and normal saline for Postoperative Wound Haemorrhage. Completed, enrolled 124 participants across 1 site.
Detailed Summary
Bleeding after Mohs micrographic surgery for skin cancer is a low risk complication that can occur. This study aims to determine the effect of a drug, often used to reduce bleeding, called tranexamic acid when applied topically to the skin wound after surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Wound Haemorrhage
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
202120222023202420252026
First PostedSep 2020
Enrollment StartOct 2020
Primary CompletionDec 2021
TodayJul 2026
First PostedSep 9, 2020
Enrollment StartOct 8, 2020
Primary CompletionDec 30, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.8 years ago
Interventions
Tranexamic aciddrug
tranexamic acid diluted to concentration of 25ml/mg
normal salinedrug
0.9% sodium chloride